Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy

Purpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but we...

Full description

Bibliographic Details
Main Authors: Sharmi Biswas, Irina Kapitanova, Sabrina Divekar, Jimm Grimm, Ian J. Butterwick, Daniel Garren, Lawrence R. Kleinberg, Kristin J. Redmond, Michel Lacroix, Anand Mahadevan, Kenneth M. Forster
Format: Article
Language:English
Published: SAGE Publishing 2021-10-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338211039135
id doaj-4862b2224d784d2893d58514bc56e797
record_format Article
spelling doaj-4862b2224d784d2893d58514bc56e7972021-10-09T22:33:28ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382021-10-012010.1177/15330338211039135Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation TherapySharmi Biswas0Irina Kapitanova1Sabrina Divekar2Jimm Grimm3Ian J. Butterwick4Daniel Garren5Lawrence R. Kleinberg6Kristin J. Redmond7Michel Lacroix8Anand Mahadevan9Kenneth M. Forster10 , New York, NY, USA , New York, NY, USA Sackler School of Medicine, , New York, NY, USA Thomas Jefferson University, Philadelphia, PA, USA , Danville, PA, USA , New York, NY, USA , Baltimore, MD, USA , Baltimore, MD, USA , Danville, PA, USA , Danville, PA, USA , Danville, PA, USAPurpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but were not given simultaneously. This study evaluates the targeting accuracy of simultaneous radiation therapy while TTFields arrays are in place and powered on, ensuring that radiation does not interfere with TTFields and TTFields does not interfere with radiation. This is one of several options to enable TTFields to begin several weeks sooner, and opens potential for synergistic effects of combined therapy. Methods: TTFields arrays were attached to a warm saline water bath and salt was added until the TTFields generator reached the maximal 2000 mA peak-to-peak current. A ball cube phantom containing 2 orthogonal films surrounded by fiducials was placed in the water phantom, CT scanned, and a radiation treatment plan with 58 isocentric beams was created using a 3 cm circular collimator. Fiducial tracking was used to deliver radiation, the films were scanned, and end-to-end targeting error was measured with vendor-supplied software. In addition, radiation effects on electric fields generated by the TTFields system were assessed by examining logfiles generated from the field generator. Results: With TTFields arrays in place and powered on, the robotic radiosurgery system achieved a final targeting result of 0.47 mm, which was well within the submillimeter specification. No discernible effects on TTFields current output beyond 0.3% were observed in the logfiles when the radiation beam pulsed on and off. Conclusion: A robotic radiosurgery system was used to verify that radiation targeting was not adversely affected when the TTFields arrays were in place and the TTFields delivery device was powered on. In addition, this study verified that radiation delivered simultaneously with TTFields did not interfere with the generation of the electric fields.https://doi.org/10.1177/15330338211039135
collection DOAJ
language English
format Article
sources DOAJ
author Sharmi Biswas
Irina Kapitanova
Sabrina Divekar
Jimm Grimm
Ian J. Butterwick
Daniel Garren
Lawrence R. Kleinberg
Kristin J. Redmond
Michel Lacroix
Anand Mahadevan
Kenneth M. Forster
spellingShingle Sharmi Biswas
Irina Kapitanova
Sabrina Divekar
Jimm Grimm
Ian J. Butterwick
Daniel Garren
Lawrence R. Kleinberg
Kristin J. Redmond
Michel Lacroix
Anand Mahadevan
Kenneth M. Forster
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
Technology in Cancer Research & Treatment
author_facet Sharmi Biswas
Irina Kapitanova
Sabrina Divekar
Jimm Grimm
Ian J. Butterwick
Daniel Garren
Lawrence R. Kleinberg
Kristin J. Redmond
Michel Lacroix
Anand Mahadevan
Kenneth M. Forster
author_sort Sharmi Biswas
title Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
title_short Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
title_full Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
title_fullStr Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
title_full_unstemmed Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
title_sort targeting accuracy considerations for simultaneous tumor treating fields antimitotic therapy during robotic hypofractionated radiation therapy
publisher SAGE Publishing
series Technology in Cancer Research & Treatment
issn 1533-0338
publishDate 2021-10-01
description Purpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but were not given simultaneously. This study evaluates the targeting accuracy of simultaneous radiation therapy while TTFields arrays are in place and powered on, ensuring that radiation does not interfere with TTFields and TTFields does not interfere with radiation. This is one of several options to enable TTFields to begin several weeks sooner, and opens potential for synergistic effects of combined therapy. Methods: TTFields arrays were attached to a warm saline water bath and salt was added until the TTFields generator reached the maximal 2000 mA peak-to-peak current. A ball cube phantom containing 2 orthogonal films surrounded by fiducials was placed in the water phantom, CT scanned, and a radiation treatment plan with 58 isocentric beams was created using a 3 cm circular collimator. Fiducial tracking was used to deliver radiation, the films were scanned, and end-to-end targeting error was measured with vendor-supplied software. In addition, radiation effects on electric fields generated by the TTFields system were assessed by examining logfiles generated from the field generator. Results: With TTFields arrays in place and powered on, the robotic radiosurgery system achieved a final targeting result of 0.47 mm, which was well within the submillimeter specification. No discernible effects on TTFields current output beyond 0.3% were observed in the logfiles when the radiation beam pulsed on and off. Conclusion: A robotic radiosurgery system was used to verify that radiation targeting was not adversely affected when the TTFields arrays were in place and the TTFields delivery device was powered on. In addition, this study verified that radiation delivered simultaneously with TTFields did not interfere with the generation of the electric fields.
url https://doi.org/10.1177/15330338211039135
work_keys_str_mv AT sharmibiswas targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT irinakapitanova targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT sabrinadivekar targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT jimmgrimm targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT ianjbutterwick targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT danielgarren targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT lawrencerkleinberg targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT kristinjredmond targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT michellacroix targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT anandmahadevan targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
AT kennethmforster targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy
_version_ 1716830205977296896